Relay Therapeutics, Inc. (RLAY)

NASDAQ: RLAY · IEX Real-Time Price · USD

6.47

+0.07 (1.09%)

At close: Jul 2, 2024, 4:00 PM

6.56

+0.09 (1.39%)

After-hours: Jul 2, 2024, 7:22 PM EDT

Relay Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Revenue	25.55	1.38	3.03	82.65	0	Upgrade
Revenue Growth (YoY)	1749.82%	-54.41%	-96.34%	-	-	Upgrade
Gross Profit	25.55	1.38	3.03	82.65	0	Upgrade
Selling, General & Admin	74.95	65.98	57.39	38.59	13.74	Upgrade
Research & Development	330.02	246.36	172.65	99.86	70.31	Upgrade
Other Operating Expenses	0	0	134.86	0	0	Upgrade
Operating Expenses	404.97	312.33	364.89	138.45	84.05	Upgrade
Operating Income	-379.42	-310.95	-361.86	-55.8	-84.05	Upgrade
Other Expense / Income	-37.45	-20.44	2.01	-3.38	-8.74	Upgrade
Pretax Income	-341.97	-290.51	-363.87	-52.41	-75.31	Upgrade
Net Income	-341.97	-290.51	-363.87	-52.41	-75.31	Upgrade
Preferred Dividends	0	0	0	177.79	0	Upgrade
Net Income Common	-341.97	-290.51	-363.87	-230.2	-75.31	Upgrade
Shares Outstanding (Basic)	123	112	95	43	3	Upgrade
Shares Outstanding (Diluted)	123	112	95	43	3	Upgrade
Shares Change	9.22%	17.97%	123.22%	1135.17%	38.84%	Upgrade
EPS (Basic)	-2.79	-2.59	-3.82	-5.40	-21.82	Upgrade
EPS (Diluted)	-2.79	-2.59	-3.82	-5.40	-21.82	Upgrade
Free Cash Flow	-304.44	-238.55	-77.88	-104.42	-74.12	Upgrade
Free Cash Flow Per Share	-2.48	-2.13	-0.82	-2.45	-21.48	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	-	Upgrade
Operating Margin	-1485.25%	-22516.44%	-11946.58%	-67.51%	-	Upgrade
Profit Margin	-1338.66%	-21036.13%	-12012.94%	-278.51%	-	Upgrade
Free Cash Flow Margin	-1191.74%	-17273.86%	-2571.05%	-126.33%	-	Upgrade
EBITDA	-336.7	-286.38	-359.95	-48.86	-72.46	Upgrade
EBITDA Margin	-1318.03%	-20737.07%	-11883.36%	-59.12%	-	Upgrade
Depreciation & Amortization	5.27	4.13	3.93	3.55	2.85	Upgrade
EBIT	-341.97	-290.51	-363.87	-52.41	-75.31	Upgrade
EBIT Margin	-1338.66%	-21036.13%	-12012.94%	-63.41%	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).